Practise Compounded Sterile Preparations Pharmacy Certification Examination (BCSCP) with a short sample and answer explanations. These are independent learning materials, not official exam questions or a pass prediction.
Exam outline and official sources
Board of Pharmacy Specialties (BPS) · BPS BCSCP Examination Specifications: ECO creation date September 2024; effective August 1, 2025 onward, confirmed against the current BPS outline index on 2026-10-11. The workbook label maps to this examination, whose awarded credential is Board-Certified Sterile Compounding Pharmacist (BCSCP); the assigned slug is preserved.
This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.
- Compounded Sterile Preparations Pharmacy Specialty Certification
- BPS Examination Content Outlines
- BCSCP Examination Specifications — Effective August 2025
- USP <797> FAQs — Updated December 11, 2023
- USP <800> FAQs — Updated January 21, 2026
- Insanitary Conditions at Compounding Facilities — November 2020
- Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice
- FDA CGMP Questions and Answers — Production and Process Controls
- FD&C Act Provisions that Apply to Human Drug Compounding
- 2022 ISMP Guidelines for Sterile Compounding and the Safe Use of Sterile Compounding Technology
- Selected EPA-Registered Disinfectants
- DailyMed — Ceftriaxone Sodium Injection, Powder, for Solution
- CDC Summary of Recommendations — Intravascular Catheter-Related Infections
- AHRQ TeamSTEPPS — Tool: Teach-Back
- AHRQ PSNet — Root Cause Analysis
- Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C — March 2022
- NCI Dictionary of Cancer Terms — Relative Risk
- NIOSH — Managing Hazardous Drug Exposures: Information for Healthcare Settings
- Pyrogen and Endotoxins Testing: Questions and Answers, Edition 2 — March 2026
- Compounding and the FDA: Questions and Answers
Compounded Sterile Preparations Pharmacy Certification Examination (BCSCP)
Start with 20 free questions, then review the explanations and any topics you missed.
A US pharmacy operating under section 503A receives a bulk drug substance from an FDA-registered manufacturer. The substance otherwise meets the applicable eligibility requirements, but no valid certificate of analysis accompanies the shipment. What is the best receiving decision?
Compounded Sterile Preparations Pharmacy Certification Examination (BCSCP)
Flashcards
Compounded Sterile Preparations
1A2 — Gravimetric verification
Get started with Compounded Sterile Preparations Pharmacy Certification Examination (BCSCP)
Purchase your plan, then choose the module to enable. Your plan renews until canceled.
Monthly exam plan
$147 / month
About $4.90 per day
Enable one exam module after payment
Published questions, flashcards and study tools
Renews until canceled
Yearly exam plan
$1337 / year
About $3.66 per day
Enable one exam module after payment
Published questions, flashcards and study tools
Renews until canceled
Found an issue? See our content policy and report a correction.